# The PENTO Protocol in Medication-related Osteonecrosis of the Jaw

> **NCT05795647** · PHASE2 · UNKNOWN · sponsor: **University Hospital, Limoges** · enrollment: 17 (estimated)

## Conditions studied

- Medication-related Osteonecrosis of the Jaw (MRONJ)

## Interventions

- **DRUG:** Pentoxifylline+Tocopherol

## Key facts

- **NCT ID:** NCT05795647
- **Lead sponsor:** University Hospital, Limoges
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2024-02-29
- **Primary completion:** 2025-04-07
- **Final completion:** 2025-04-07
- **Target enrollment:** 17 (ESTIMATED)
- **Last updated:** 2024-03-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05795647

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05795647, "The PENTO Protocol in Medication-related Osteonecrosis of the Jaw". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT05795647. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*